Gamida Cell (GMDA) Revenue & Revenue Breakdown
Gamida Cell Revenue Highlights
Latest Revenue (Y)
$1.78M
Latest Revenue (Q)
$890.00K
Gamida Cell Revenue by Period
Gamida Cell Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | $1.78M | 100.00% |
2022-12-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2019-12-31 | - | 100.00% |
2018-12-31 | - | 100.00% |
2017-12-31 | - | 100.00% |
2016-12-31 | - | - |
Gamida Cell Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-03-31 | $890.00K | -19.89% |
2023-12-31 | $1.11M | 65.08% |
2023-09-30 | $673.00K | 100.00% |
2023-06-30 | - | 100.00% |
2023-03-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2022-09-30 | - | 100.00% |
2022-06-30 | - | 100.00% |
2022-03-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2021-09-30 | - | 100.00% |
2021-06-30 | - | 100.00% |
2021-03-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2020-09-30 | - | 100.00% |
2020-06-30 | - | 100.00% |
2020-03-31 | - | 100.00% |
2019-12-31 | - | 100.00% |
2019-09-30 | - | 100.00% |
2019-06-30 | - | 100.00% |
2019-03-31 | - | 100.00% |
2018-12-31 | - | 100.00% |
2018-09-30 | - | 100.00% |
2018-06-30 | - | 100.00% |
2018-03-31 | - | 100.00% |
2017-12-31 | - | 100.00% |
2017-09-30 | - | 100.00% |
2017-06-30 | - | - |
Gamida Cell Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
MCRB | Seres Therapeutics | $126.33M | - |
ARDX | Ardelyx | $124.46M | $98.24M |
HOOK | HOOKIPA Pharma | $20.13M | - |
BLRX | BioLineRx | $4.80M | $6.86M |
GMDA | Gamida Cell | $1.78M | $890.00K |
LXRX | Lexicon Pharmaceuticals | $1.20M | $1.74M |
IOVA | Iovance Biotherapeutics | $1.19M | $58.55M |
IBRX | ImmunityBio | $622.00K | $1.05M |
XFOR | X4 Pharmaceuticals | - | $560.00K |
DAWN | Day One Biopharmaceuticals | - | $20.07M |
INZY | Inozyme Pharma | - | - |
TERN | Terns Pharmaceuticals | - | - |